Home NDC 71687-3003 Pamprin Multi-Symptom
Product NDC 71687-3003
11-digit product format 716873003
Labeler code 71687
Product ID 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form TABLET
Route ORAL
Labeler Focus Consumer Healthcare, LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2016-06-01
Substance PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-4 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-4 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-4 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-4 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-4 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-4 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-4 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Pamprin Multi-Symptom
Brand name suffix Maximum Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PYRILAMINE MALEATE 15 mg/1 PAMABROM 25 mg/1 ACETAMINOPHEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R35D29L3ZA Internal UNII lookup UA8U0KJM72 Internal UNII lookup 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1052637 Internal RxNorm lookup 1053852 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 20 in 1 BOTTLE, PLASTIC TABLET 20 5 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET 40 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71687-3003 PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC] 4 Current NDC, Legacy NDC, 4 package rows 20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 48 of 79 · 1,579 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aspirin 81 mg ASPIRIN Asclemed USA, Inc. 878dab20-668b-4d7a-a5f8-794a587564d5 2025-02-13 Warnings Exact identifier application number: M013 ACETAMINOPHEN ACETAMINOPHEN CVS HEALTH CORP bbc48c9e-7eb8-2c67-e053-2a95a90a8552 2025-02-13 Warnings Exact identifier application number: M013 Dye Free Infants Pain and Fever ACETAMINOPHEN CVS 1fde0f7c-4b5b-ae9c-e063-6394a90afa41 2025-02-13 Warnings Exact identifier application number: M013 NOTTS - Extra Strength 500 mg ACETAMINOPHEN VIVUNT PHARMA LLC e677f43d-b4ce-e5b0-e053-2a95a90ad67e 2025-02-12 Warnings Exact identifier application number: M013 Acetaminophen, Aspirin, Caffeine ACETAMINOPHEN, ASPIRIN, CAFFEINE LEADER/ Cardinal Health 110, Inc. b3773f02-02a9-33c8-e053-2995a90a2235 2025-02-11 Warnings Exact identifier application number: M013 EXTRA STRENGTH ACETAMINOPHEN ACETAMINOPHEN TIME CAP LABORATORIES, INC. c9f80d24-bd05-e1ce-e053-2995a90aa646 2025-02-10 Warnings Exact identifier application number: M013 Low dose Aspirin ASPIRIN 81 MG DELAYED RELEASE TABLETS WALGREENS c25c55aa-9932-0a55-e053-2a95a90a3d1e 2025-02-10 Warnings Exact identifier application number: M013 AeroTab Pain Reliever PAIN RELIEVER Aero Healthcare 40e2b5ea-a8ea-f1c6-e063-6394a90a1e6f 2025-02-10 Warnings Exact identifier application number: M013 Enteric Coated Aspirin Regular Strength ASPIRIN Time-Cap Labs, Inc 5fbd8bb3-46f9-4089-9a21-b6af97a06106 2025-02-08 Warnings Exact identifier application number: M013 ACETAMINOPHEN ACETAMINOPHEN TIME CAP LABS INC c193dbc0-cc80-4a7c-aa29-457a20edf835 2025-02-08 Warnings Exact identifier application number: M013 Daytime Severe Cold and Flu ACETAMINOPHEN, DEXTROMETHORPHAN HBR Genexa Inc. 22f23aeb-f874-6e54-e063-6394a90a9565 2025-02-07 Warnings Exact identifier application number: M013 Pain Relief ACETAMINOPHEN BETTER LIVING BRANDS LLC. f3008928-c555-64ad-e053-2995a90a7307 2025-02-05 Warnings Exact identifier application number: M013 Aspirin 81mg ASPIRIN BETTER LIVING BRANDS LLC. f300dfbc-7137-79d1-e053-2995a90a636e 2025-02-05 Warnings Exact identifier application number: M013 Low dose aspirin 81mg ASPIRIN BETTER LIVING BRANDS LLC. f300c30b-ab1a-a1b4-e053-2a95a90a1294 2025-02-05 Warnings Exact identifier application number: M013 Pain Reliever PM ACETAMINOPHEN, DIPHENHYDRAMINE HCL Strategic Sourcing Services LLC 5d174187-cf89-41ff-9a64-10e0276daf17 2025-02-05 Warnings Exact identifier application number: M013 good sense pain relief ACETAMINOPHEN Bryant Ranch Prepack c226205d-7c3c-49af-b3e2-fc7b09ad7857 2025-02-05 Warnings Exact identifier application number: M013 Dye Free Childrens Acetaminophen ACETAMINOPHEN PAI Holdings, LLC dba PAI Pharma a69fca9d-c0a0-4321-bf03-5c8e99cc07cc 2025-02-04 Warnings Exact identifier application number: M013 TENSION HEADACHE RELIEF ACETAMINOPHEN-CAFFEINE TARGET CORPORATION 8ed1679d-d3a1-11b1-e053-2995a90a61ad 2025-01-31 Warnings Exact identifier application number: M013 ValuMeds Extra Strength Headache Relief ACETAMINOPHEN, ASPIRIN, CAFFEINE Cabinet Health P.B.C. 0f864e73-e4b8-4e23-8990-8439ac17bd58 2025-01-31 Warnings Exact identifier application number: M013 Extra Strength Pain Reliever ACETAMINOPHEN TABLETS 500 MG WALGREENS c25bfe92-0196-0489-e053-2995a90abea1 2025-01-30 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71687-3003-1 71687300301 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current 71687-3003-4 71687300304 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current